Prognostic criteria for different diseases of prostate

Cover Page
  • Authors: Kostin AA1, Andriukhin MI1, Pul’bere SA1, Babichenko II1, Motin PI2, Agaev NK2
  • Affiliations:
    1. Peoples’ Friendship University of Russia
    2. SBHI “City Clinical Hospital № 29”
  • Issue: No 4 (2015)
  • Pages: 75-83
  • Section: Articles
  • URL: http://journals.rudn.ru/medicine/article/view/2417
  • Cite item

Abstract


The study involved 263men over 45 years with different diseases of the prostate, including the routine methods and complex immunohistochemical techniques. The use of this complex allows to increase the accuracy of differential diagnosis of the prostate diseases in the primary biopsies and detection of prostate cancer at the localized stage, reduce the number of unreasonable repeated biopsies, the need for repeated hospitalizations, postoperative complications and facilitate the work of a doctor. Results of five-year follow up of patients with verified prostate adenocarcinoma identified predictors of hormone-resistant cancer, which will help increase the efficiency of the treatment of these patients.

About the authors

A A Kostin

Peoples’ Friendship University of Russia

Email: info@mnioi.ru
Department of Urology and Surgical Nephrology

M I Andriukhin

Peoples’ Friendship University of Russia

Email: valeriya-andrew@mail.ru
Department of Urology and Surgical Nephrology

S A Pul’bere

Peoples’ Friendship University of Russia

Email: pulpiv@mail.ru
Department of Urology and Surgical Nephrology

I I Babichenko

Peoples’ Friendship University of Russia

Email: babichenko@list.ru
Department of Pathological Anatomy

P I Motin

SBHI “City Clinical Hospital № 29”

Email: p.motin@mail.ru
Urology Department

N K Agaev

SBHI “City Clinical Hospital № 29”

Email: nazaragaev@mail.ru
Urology Department

References

Statistics

Views

Abstract - 88

PDF (Russian) - 44

Cited-By



Copyright (c) 2015 Костин А.А., Андрюхин М.И., Пульбере С.А., Бабиченко И.И., Мотин П.И., Агеев Н.К.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies